115 related articles for article (PubMed ID: 12507306)
1. Molecular therapeutics in prostate cancer.
Nicholson B; Theodorescu D
Histol Histopathol; 2003 Jan; 18(1):275-98. PubMed ID: 12507306
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive therapy for men with high risk localized and locally advanced prostate cancer: targeting disseminated tumor cells.
Sokoloff MH; Rinker-Schaeffer CW; Chung LW; Brendler CB
J Urol; 2004 Dec; 172(6 Pt 2):2539-44. PubMed ID: 15538203
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
4. Molecular biology of prostate cancer.
Karayi MK; Markham AF
Prostate Cancer Prostatic Dis; 2004; 7(1):6-20. PubMed ID: 14999233
[TBL] [Abstract][Full Text] [Related]
5. IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer.
Pencik J; Wiebringhaus R; Susani M; Culig Z; Kenner L
Swiss Med Wkly; 2015; 145():w14215. PubMed ID: 26691865
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular biology of prostate cancer.
Lalani el-N ; Laniado ME; Abel PD
Cancer Metastasis Rev; 1997 Jun; 16(1-2):29-66. PubMed ID: 9156279
[TBL] [Abstract][Full Text] [Related]
7. New prospectives of prostate cancer gene therapy: molecular targets and animal models.
Hsieh CL; Chung LW
Crit Rev Eukaryot Gene Expr; 2001; 11(1-3):77-120. PubMed ID: 11693967
[TBL] [Abstract][Full Text] [Related]
8. Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.
Ko SC; Gotoh A; Thalmann GN; Zhau HE; Johnston DA; Zhang WW; Kao C; Chung LW
Hum Gene Ther; 1996 Sep; 7(14):1683-91. PubMed ID: 8886839
[TBL] [Abstract][Full Text] [Related]
9. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
McCarty MF
Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer gene therapy clinical trials.
Freytag SO; Stricker H; Movsas B; Kim JH
Mol Ther; 2007 Jun; 15(6):1042-52. PubMed ID: 17406342
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis in prostate cancer: progressive and therapeutic implications (Review).
Wang G; Reed E; Li QQ
Int J Mol Med; 2004 Jul; 14(1):23-34. PubMed ID: 15202013
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy of prostate cancer: p53, suicidal genes, and other targets.
Boulikas T
Anticancer Res; 1997; 17(3A):1471-505. PubMed ID: 9179186
[TBL] [Abstract][Full Text] [Related]
13. Death receptor-induced cell death in prostate cancer.
Guseva NV; Taghiyev AF; Rokhlin OW; Cohen MB
J Cell Biochem; 2004 Jan; 91(1):70-99. PubMed ID: 14689583
[TBL] [Abstract][Full Text] [Related]
14. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
15. Treatment options in androgen-independent prostate cancer.
Lara PN; Meyers FJ
Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
[TBL] [Abstract][Full Text] [Related]
16. Signal transduction in prostate cancer progression.
Gioeli D
Clin Sci (Lond); 2005 Apr; 108(4):293-308. PubMed ID: 15603554
[TBL] [Abstract][Full Text] [Related]
17. Resistance to apoptosis in prostate cancer cells.
Howell SB
Mol Urol; 2000; 4(3):225-9;discussion 231. PubMed ID: 11062378
[TBL] [Abstract][Full Text] [Related]
18. Molecular heterogeneity in prostate cancer: can TP53 mutation unravel tumorigenesis?
Roy-Burman P; Zheng J; Miller GJ
Mol Med Today; 1997 Nov; 3(11):476-82. PubMed ID: 9430782
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of prostate cancer progression to androgen independence.
McPhaul MJ
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):373-88. PubMed ID: 18471793
[TBL] [Abstract][Full Text] [Related]
20. The development of androgen-independent prostate cancer.
Feldman BJ; Feldman D
Nat Rev Cancer; 2001 Oct; 1(1):34-45. PubMed ID: 11900250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
